THE LATEST WORD

Top Industry Stories – October 28, 2009

Posted on October 28th, 2009 | by Rxmedyn | No Comments »

Novartis Prepares For Diovan Patent Expiries; Looks To New Product Launches (Pinksheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Getting Past FDA’s HALT: Can Amgen Escape New Trial Requirement For Prolia With Data From SRE Studies? (Pinksheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Comparative Effectiveness: Pharma Needs To Take Charge, Quintiles Says (Pinksheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

UK trust sues Amgen, Wyeth over Enbrel patent (Reuters)

Pfizer, Indian NGO tie up on public health (RxPGnes)

Watson, Barr settle patent dispute (Drugstorenews)

Obama girls get H1N1 vaccinations amid shortages; Peramivir approved by FDA (Examiner)

Microbix plans huge new vax facility; Novartis wins Ilaris approval (FierceBiotech)

Novartis Champions Renewable Energy With New Vacaville Solar Array (Reuters)

Leave a Reply

You must be logged in to post a comment.